Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.

Current pharmaceutical biotechnology - 1 Jan 2017

Cecchin Erika, Roncato Rossana, Guchelaar Hendrik J, Toffoli Giuseppe

Abstract excerpt

Although the clinical validity of a number of pharmacogenetic markers is nowadays a matter of fact, and led authoritative scientific consortia as the Dutch Pharmacogenetic Working Group (DPWG) and the Clinical Pharmacogenomics Implementation Consortium (CPIC) to publish pharmacogenetic guidelines, the clinical implementation in real life remains challenging. Ubiquitous Pharmacogenomics (U-PGx) program is a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Pharmacogenetics

Share to Practice Guidelines as Topic

Share to Practice Patterns, Physicians'

Share to Precision Medicine

Source

Identifiers

PMID: 28044932
DOI: 10.2174/1389201018666170103103619

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.PMID 28044932Read ↗

Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.Semantic proximity Read ↗

Pharmacogenetic Testing: A Tool for Personalized Drug Therapy OptimizationSemantic proximity Read ↗

Progress towards the integration of pharmacogenomics in practice.Semantic proximity Read ↗

Relevance of pharmacogenomics for developing countries in EuropeSemantic proximity Read ↗

Emerging strategies and applications of pharmacogenomics.Semantic proximity Read ↗

[Pharmacogenomics: hype or hope?].Semantic proximity Read ↗

Theranostics in primary care: pharmacogenomics tests and beyond.Semantic proximity Read ↗

Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activitySemantic proximity Read ↗

Requirements for comprehensive pharmacogenetic genotyping platforms.Semantic proximity Read ↗

Pharmacogenomics: Current State-of-the-ArtSemantic proximity Read ↗

Pharmacogenomics in the era of next generation sequencing – from byte to bedsideSemantic proximity Read ↗

Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.